Article Text
PDFPrognosis
Nested case-control study
Inhaled anticholinergic medications in older men with chronic obstructive pulmonary disorder are associated with increased odds of acute urinary retention
Statistics from Altmetric.com
Footnotes
-
Competing interests DDS has received grants from Pfizer and Boehringer Ingelheim, makers of inhaled anticholinergics, as well as from AstraZeneca and GlaxoSmithKline, makers of long-acting β-2 agonists.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions